Editor’s note: This is the third part in a weekly series examining the lasting effects of the current economy on the legal industry.
When Eli Lilly & Co. settled a whistleblower suit in January for $1.42 billion over allegations it improperly marketed an anti-psychotic drug, Duane Morris was in the unusual spot of representing the plaintiffs along with personal injury firm Sheller P.C.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
